Pomalidomide Treatment in Patients With Kaposi Sarcoma

Summary

This phase II trial studies the effect of pomalidomide in treating patients with Kaposi sarcoma. Pomalidomide is a cancer fighting drug that stops the growth of blood vessels, stimulates the immune system, and may kill cancer cells.

Timeline

Start

2022-03-18

Primary completion

2026-10-01

Completion

2026-10-01

Drugs

Indications